Combo Product Excitement: Large Players On Look-Out For Early-Stage Deals
This article was originally published in The Gray Sheet
Executive Summary
Heightened corporate interest in innovative drug-delivery technologies offers greater opportunities for small device firms to attract larger company investment, venture capitalists say
You may also be interested in...
ImaRx’ Combo Treatment For Stroke To Wrap Up Phase I/II Trial By Mid-2008
ImaRx is on track to complete enrollment in a Phase I/II dose escalation study by mid-2008 for its combo product SonoLysis, which uses ultrasound and microbubbles to treat acute ischemic stroke
ImaRx’ Combo Treatment For Stroke To Wrap Up Phase I/II Trial By Mid-2008
ImaRx is on track to complete enrollment in a Phase I/II dose escalation study by mid-2008 for its combo product SonoLysis, which uses ultrasound and microbubbles to treat acute ischemic stroke
Boston Scientific COO Praises FDA Combo Efforts, Warns of Grueling Process
FDA's combination products approval process is effective at offsetting some challenges to developing and marketing drug-device pairings, according to Boston Scientific Chief Operating Officer Paul LaViolette